Drug · DIN 02533995
QULIPTA
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since March 1, 2023; first marketed March 1, 2023.
- Drug Identification Number (DIN)
- 02533995
- Company (DIN owner)
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Atogepant N02CD07
- Class
- Human
- Record last updated
- June 12, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ATOGEPANT | 60 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 22, 2022: NOC 29754New Drug Submission (NDS)
Other DINs named QULIPTA
- DIN 02533979 · Marketed
- DIN 02533987 · Marketed